[
    [
        {
            "time": "",
            "original_text": "券商为何密集“补血”？年内定增、配股超千亿，中小券商突围路径还有哪些？",
            "features": {
                "keywords": [
                    "券商",
                    "补血",
                    "定增",
                    "配股",
                    "中小券商",
                    "突围路径"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "证券"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "券商为何密集“补血”？年内定增、配股超千亿，中小券商突围路径还有哪些？",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]